• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性心脏病相关肺动脉高压患儿肺部微生物组和代谢组特征的改变

Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease.

作者信息

Ma Runwei, Cheng Liming, Song Yi, Sun Yi, Gui Wenting, Deng Yao, Xie Chao, Liu Min

机构信息

Department of Cardiovascular Surgery, Fuwai Yunnan Cardiovascular Hospital, Kunming, China.

Department of Anesthesiology, Kunming Children's Hospital, Kunming, China.

出版信息

Front Med (Lausanne). 2022 Jul 28;9:940784. doi: 10.3389/fmed.2022.940784. eCollection 2022.

DOI:10.3389/fmed.2022.940784
PMID:35966852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9366172/
Abstract

BACKGROUNDS

Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary vascular functional and structural changes, resulting in increased pulmonary vascular resistance and eventually right heart failure and death. Congenital Left-to-Right shunts (LTRS) is one type of congenital heart disease (CHD) and PAH associated with the congenital Left-to-Right shunt (PAH-LTRS) is a severe disease in children. However, changes in the lung microbiome and their potential impact on PAH-LTRS have not been not fully studied. We hypothesized that lung microbiota and their derived metabolites have been disturbed in children with PAH-LTRS, which might contribute to the progression and outcomes of PAH-LTRS.

METHODS

In this study, 68 age- and sex-matched children of three different groups (patients with PAH-LTRS cohort, patients with LTRS but have no pathologic features of PAH cohort, and healthy reference cohort) were enrolled in the current study. Bronchoalveolar lavage fluid samples from these participants were conducted for multi-omics analysis, including 16S rRNA sequencing and metabolomic profiling. Data progressing and integration analysis were performed to identify pulmonary microbial and metabolic characteristics of PAH-LTRS in children.

RESULTS

We found that microbial community density was not significantly altered in PAH-LTRS based on α-diversity analysis. Microbial composition analysis indicated phylum of Bacteroidetes was that less abundant while Lactobacillus, Alicycliphilus, and Parapusillimonas were significantly altered and might contribute to PAH in children with LTRS. Moreover, metabolome profiling data showed that metabolites involved in Purine metabolism, Glycerophospholipid metabolism, Galactose metabolism, and Pyrimidine metabolism were also significantly disturbed in the PAH-LTRS cohort. Correlation analysis between microbes and metabolites indicated that alterations in the microbial composition from the lung microbiota could eventually result in the disturbance in certain metabolites, and might finally contribute to the pathology of PAH-LTRS.

CONCLUSION

Lung microbial density was not significantly altered in patients with PAH-LTRS. Composition analysis results showed that the relative microbiome abundance was different between groups. Metabolome profiling and correlation analysis with microbiota showed that metabolome also altered in children with PAH-LTRS. This study indicated that pulmonary microbes and metabolites disturbed in PAH-LTRS could be potentially effective biomarkers and provides valuable perspectives on clinical diagnosis, treatment, and prognosis of pediatric PAH-LTRS.

摘要

背景

肺动脉高压(PAH)的特征是肺血管功能和结构逐渐发生变化,导致肺血管阻力增加,最终引发右心衰竭和死亡。先天性左向右分流(LTRS)是先天性心脏病(CHD)的一种类型,与先天性左向右分流相关的肺动脉高压(PAH-LTRS)是儿童中的一种严重疾病。然而,肺微生物群的变化及其对PAH-LTRS的潜在影响尚未得到充分研究。我们假设PAH-LTRS患儿的肺微生物群及其衍生代谢产物受到干扰,这可能有助于PAH-LTRS的进展和预后。

方法

在本研究中,纳入了68名年龄和性别匹配的来自三个不同组的儿童(PAH-LTRS队列患者、有LTRS但无PAH病理特征的队列患者以及健康对照队列)。对这些参与者的支气管肺泡灌洗液样本进行多组学分析,包括16S rRNA测序和代谢组学分析。进行数据处理和整合分析,以确定儿童PAH-LTRS的肺部微生物和代谢特征。

结果

基于α多样性分析,我们发现PAH-LTRS中的微生物群落密度没有显著改变。微生物组成分析表明,拟杆菌门的丰度较低,而乳酸杆菌属、嗜环脂菌属和副小单胞菌属有显著变化,可能与LTRS患儿的PAH有关。此外,代谢组学分析数据显示,参与嘌呤代谢、甘油磷脂代谢、半乳糖代谢和嘧啶代谢的代谢产物在PAH-LTRS队列中也受到显著干扰。微生物与代谢产物之间的相关性分析表明,肺微生物群的微生物组成变化最终可能导致某些代谢产物的紊乱,并最终可能导致PAH-LTRS的病理改变。

结论

PAH-LTRS患者的肺微生物密度没有显著改变。组成分析结果表明,不同组之间微生物组的相对丰度不同。代谢组学分析以及与微生物群的相关性分析表明,PAH-LTRS患儿的代谢组也发生了改变。本研究表明,PAH-LTRS中受干扰的肺部微生物和代谢产物可能是潜在的有效生物标志物,并为儿童PAH-LTRS的临床诊断、治疗和预后提供了有价值的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/acf4ff8514e3/fmed-09-940784-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/d23b168ccbff/fmed-09-940784-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/816a55b0b3ec/fmed-09-940784-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/98c615185cff/fmed-09-940784-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/8b786e9af525/fmed-09-940784-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/d594f728c887/fmed-09-940784-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/acf4ff8514e3/fmed-09-940784-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/d23b168ccbff/fmed-09-940784-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/816a55b0b3ec/fmed-09-940784-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/98c615185cff/fmed-09-940784-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/8b786e9af525/fmed-09-940784-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/d594f728c887/fmed-09-940784-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d388/9366172/acf4ff8514e3/fmed-09-940784-g0006.jpg

相似文献

1
Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease.先天性心脏病相关肺动脉高压患儿肺部微生物组和代谢组特征的改变
Front Med (Lausanne). 2022 Jul 28;9:940784. doi: 10.3389/fmed.2022.940784. eCollection 2022.
2
NMR-Based Metabolomic Analysis of Plasma in Patients with Adult Congenital Heart Disease and Associated Pulmonary Arterial Hypertension: A Pilot Study.基于核磁共振的成人性先天性心脏病及相关肺动脉高压患者血浆代谢组学分析:一项初步研究。
Metabolites. 2022 Sep 8;12(9):845. doi: 10.3390/metabo12090845.
3
Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.先天性体-肺分流及艾森曼格综合征相关肺动脉高压的管理
Drugs. 2008;68(8):1049-66. doi: 10.2165/00003495-200868080-00004.
4
Gut microbiome and metabolome profiling in coal workers' pneumoconiosis: potential links to pulmonary function.矿工尘肺的肠道微生物组和代谢组特征:与肺功能的潜在关联。
Microbiol Spectr. 2024 Nov 5;12(11):e0004924. doi: 10.1128/spectrum.00049-24. Epub 2024 Sep 16.
5
Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.肺动脉高压患者的肠道微生物组具有促炎作用,且循环微生物代谢物发生改变。
Am J Respir Crit Care Med. 2023 Mar 15;207(6):740-756. doi: 10.1164/rccm.202203-0490OC.
6
[Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].[先天性心脏病相关肺动脉高压患者不同亚型的死亡危险因素及临床特征]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):315-322. doi: 10.3760/cma.j.cn112148-20190628-00364.
7
[Correlation between endogenous sulfur dioxide and homocysteine in children with pulmonary arterial hypertension associated with congenital heart disease].先天性心脏病相关性肺动脉高压患儿内源性二氧化硫与同型半胱氨酸的相关性
Zhonghua Er Ke Za Zhi. 2014 Aug;52(8):625-9.
8
Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension.肺动脉高压大鼠模型中肠道微生物组和代谢组的变化。
Bioengineered. 2021 Dec;12(1):5173-5183. doi: 10.1080/21655979.2021.1952365.
9
The prognostic implications of perioperative endogenous hydrogen sulfide and nitric oxide levels in children with congenital heart disease complicated by pulmonary arterial hypertension.围术期内源性硫化氢和一氧化氮水平对合并肺动脉高压的先天性心脏病患儿的预后意义。
Eur J Pediatr. 2021 Jun;180(6):1915-1922. doi: 10.1007/s00431-020-03897-w. Epub 2021 Feb 8.
10
Pulmonary vasodilators can lead to various complications in pulmonary "arterial" hypertension associated with congenital heart disease.肺血管扩张剂可导致先天性心脏病相关的肺动脉高压出现各种并发症。
Heart Vessels. 2020 Sep;35(9):1307-1315. doi: 10.1007/s00380-020-01604-1. Epub 2020 Apr 13.

引用本文的文献

1
Advancing the fight against tuberculosis: integrating innovation and public health in diagnosis, treatment, vaccine development, and implementation science.推进结核病防治工作:在诊断、治疗、疫苗研发及实施科学方面整合创新与公共卫生。
Front Med (Lausanne). 2025 Aug 25;12:1596579. doi: 10.3389/fmed.2025.1596579. eCollection 2025.
2
Integrated multi-omics analysis of the microbial profile characteristics associated with pulmonary arterial hypertension in congenital heart disease.先天性心脏病相关肺动脉高压微生物谱特征的综合多组学分析
Microbiol Spectr. 2024 Oct 29;12(12):e0180824. doi: 10.1128/spectrum.01808-24.
3

本文引用的文献

1
Analysis of Conjunctival Sac Microbiome in Dry Eye Patients With and Without Sjögren's Syndrome.伴有和不伴有干燥综合征的干眼症患者结膜囊微生物群分析
Front Med (Lausanne). 2022 Mar 8;9:841112. doi: 10.3389/fmed.2022.841112. eCollection 2022.
2
Eisenmenger Syndrome: JACC State-of-the-Art Review.艾森曼格综合征:美国心脏病学会最新综述
J Am Coll Cardiol. 2022 Mar 29;79(12):1183-1198. doi: 10.1016/j.jacc.2022.01.022.
3
Food for Thought: The Emerging Role of Intestinal Microbiota in Pulmonary Arterial Hypertension.值得思考的问题:肠道微生物群在肺动脉高压中的新作用
Study on the fourof Pfaffia glomerata based on the metabolomics technology and comparison of Dangshen () in the equivalent substitution prescription.
基于代谢组学技术的四棱豆研究及等效替代处方中党参的比较。
J Tradit Chin Med. 2024 Aug;44(4):713-721. doi: 10.19852/j.cnki.jtcm.20240521.001.
4
Genetic association and bidirectional Mendelian randomization for causality between gut microbiota and six lung diseases.肠道微生物群与六种肺部疾病之间因果关系的遗传关联和双向孟德尔随机化研究
Front Med (Lausanne). 2023 Dec 15;10:1279239. doi: 10.3389/fmed.2023.1279239. eCollection 2023.
5
Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis.宿主转录调控基因与微生物组网络通过免疫受体相互作用,建立口腔-肠道-肺部轴的正常和肿瘤多组学元模型。
Int J Mol Sci. 2023 Nov 23;24(23):16638. doi: 10.3390/ijms242316638.
6
Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.代谢组学在肺动脉高压中的应用——揭示棘手病理黑暗面的有用工具。
Int J Mol Sci. 2023 Aug 25;24(17):13227. doi: 10.3390/ijms241713227.
7
Pulmonary arterial hypertension associated with congenital heart disease: An omics study.先天性心脏病相关肺动脉高压:一项组学研究。
Front Cardiovasc Med. 2023 Mar 10;10:1037357. doi: 10.3389/fcvm.2023.1037357. eCollection 2023.
8
Metabolomics: A New Tool in Our Understanding of Congenital Heart Disease.代谢组学:我们理解先天性心脏病的新工具。
Children (Basel). 2022 Nov 24;9(12):1803. doi: 10.3390/children9121803.
Am J Respir Cell Mol Biol. 2022 Apr;66(4):361-362. doi: 10.1165/rcmb.2022-0005ED.
4
Metabolic Reprogramming of the Right Ventricle and Pulmonary Arteries in a Flow-Associated Pulmonary Arterial Hypertension Rat Model.血流相关性肺动脉高压大鼠模型中右心室和肺动脉的代谢重编程
ACS Omega. 2021 Dec 27;7(1):1273-1287. doi: 10.1021/acsomega.1c05895. eCollection 2022 Jan 11.
5
Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH.儿童严重肺动脉高压行双侧肺移植后右心室收缩功能完全恢复。
J Heart Lung Transplant. 2022 Feb;41(2):187-198. doi: 10.1016/j.healun.2021.10.014. Epub 2021 Oct 29.
6
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion.结直肠癌患者肠道细菌通过分泌丁酸盐促进肿瘤发生。
Nat Commun. 2021 Sep 28;12(1):5674. doi: 10.1038/s41467-021-25965-x.
7
Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension.肺动脉高压大鼠模型中肠道微生物组和代谢组的变化。
Bioengineered. 2021 Dec;12(1):5173-5183. doi: 10.1080/21655979.2021.1952365.
8
Extracellular vesicles of P. gingivalis-infected macrophages induce lung injury.牙龈卟啉单胞菌感染的巨噬细胞外囊泡诱导肺损伤。
Biochim Biophys Acta Mol Basis Dis. 2021 Nov 1;1867(11):166236. doi: 10.1016/j.bbadis.2021.166236. Epub 2021 Aug 11.
9
Protective effect of isosteviol sodium against LPS-induced multiple organ injury by regulating of glycerophospholipid metabolism and reducing macrophage-driven inflammation.异甜菊醇钠通过调节甘油磷脂代谢和减少巨噬细胞驱动的炎症来对抗 LPS 诱导的多器官损伤的保护作用。
Pharmacol Res. 2021 Oct;172:105781. doi: 10.1016/j.phrs.2021.105781. Epub 2021 Jul 22.
10
Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy.肺癌中微生物组失调与表观遗传调控:从发病机制到治疗。
Semin Cancer Biol. 2022 Nov;86(Pt 3):732-742. doi: 10.1016/j.semcancer.2021.07.005. Epub 2021 Jul 15.